GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Question] the UK — has anyone got a straight answer on reimbursement — 13 comments in the full submission. View in context.
150
c/glp1eu·submitted 7 months ago by u/milan_mensah

[Question] the UK — has anyone got a straight answer on reimbursement

Questionbranch of 6 comments

the UK — has anyone got a straight answer on reimbursement, and I want the answer with the reasoning attached rather than just the conclusion. The structure that makes this board make sense, once. Marketing authorisation for these products is granted centrally, which is why the same product exists across the union.…

Read the full submission and all 13 comments →

This branch

6 comments, started 7 months ago
u/marisol_kravchenko20 points·7 months ago·edited

Cross-border prescription recognition exists under EU rules but is conditional and narrower than commonly assumed, with requirements about the prescription’s form and content.

replysharereportpermalink
u/dario_petrescu13 points·7 months ago·edited

Right, and a shortage notice in one country tells you very little about the next one along.

replysharereportpermalink
u/naomi_erdogan13 points·7 months ago·edited

Read the published reimbursement criteria where I live rather than asking. Took twenty minutes and answered everything.

replysharereportpermalink
u/rt_shift_reggie9 points·7 months ago

Correcting myself upthread: the criterion I quoted was updated for this year.

replysharereportpermalink
u/cormac_erdogan7 points·7 months ago

Disagree. That is one member state’s reimbursement rule and it does not generalise across the union.

replysharereportpermalink
load more comments (1) →

← back to the whole thread

About c/glp1eu

European access, country by country: prescription routes, reimbursement reality, pharmacy stock, EMA notices and the fact that "EU rules" is usually a national question wearing a European hat.

32kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
More in c/glp1eu
c/glp1eu rules
  1. Tag your country in the title. Bare "EU" questions get a template reply.
  2. Pricing posts need the date and the currency.
  3. EMA and national agency claims need a citation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/eu_apotheke_au/nl_verzekeringu/nordic_pricingu/spain_receta
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →